Australia's most trusted
source of pharma news
Wednesday, 24 June 2026
Posted 24 June 2026 PM
Eighteen submissions recommended by the PBAC over the past two years, covering new drugs, biosimilars, and new indications could be added to the PBS next month.
Most of the submissions (14) moved into the government processes stage, also known as the last stage before listing occurs, in May.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.